Serology, or antibody, tests have a place in the fight against COVID-19.
Learn what your COVID-19 antibody tests results mean.
Schedule antibody testing at one of our RapidScreen locations.
Serum COVID-19 Antibody screening can help determine who has been exposed and find asymptomatic individuals who are currently infected.
Establish the rate of spread within communities by evaluating the percentages of a populace that tests positive for antibodies.
Recent evidence indicates that plasma donations from people with COVID antibodies help the critically ill recover from the disease more quickly.
Rapid COVID Antibody Screening is the most efficient means to quickly screen the public and determine who may require more formal testing.
Catching asymptomatic cases can play a role in stopping community spread early by accelerating distancing measures and reaching out to potential contacts.
Employees who test negative or show some immunity (IgG) for COVID-19 can get back to work with less fear of asymptomatic spread. Employees who test positive for early antibodies (IgM) can be receive further testing for the presence of virus.
While the level of acquired immunity due to the presence of antibodies is still being studied, and there is a latent period where antibodies will not be detected, antibody testing offers the quickest, most economical approach to group screening of the public.
The cost of screening employees for COVID-19 antibodies depends on the number of employees and locations. RapidScreen provides the medical professionals and supplies necessary for screening your group.
Base cost is a $200 per day site fee + $79.99 per person
COVID Testing may be reimbursable by medical insurance and federal programs for qualified individuals to help reduce out-of-pocket costs.
10K+ screenings can be completed per location per week. Antibody screening provides vital information that allows healthy individuals to return to work and the economy to restart.
Unexposed and recovered individuals can get back to work. Recovered individuals have likely acquired some level of immunity and can donate plasma to help treat critically ill patients
People are tested with a simple finger prick without leaving their cars, a much less invasive method than nasal swab. Person-to-person exposure is minimal and risk of contracting the sickness in a typical medical setting is reduced.
Antibody screening is the best large-scale methodology to identify those who have been exposed, are currently infected, are asymptomatic, or have not been exposed at all.
Healthy individuals should be able to get back to work.
Medical clinics and PCR (nasal swab) testing centers will be less overwhelmed with otherwise healthy, or slightly sick and concerned patients. PCR testing still has a role and can easily handle the small percentage who screen positive for antibodies or are otherwise symptomatic.
A positive antibody screen + positive PCR = currently contagious. A positive antibody screen + negative PCR = recovered. A negative antibody screen = not likely exposed. Healthy individuals can resume normal life. Weekly follow-ups can be considered to assure ongoing negative status.
You most likely have not been infected with SARS-CoV-2 (the virus that causes COVID-19).
Continue to follow CDC, city, county, and state guidelines to prevent exposure.
IgM(+) and IgG(-)
There is a high probability that you have been infected recently with SARS-CoV-2 (the virus that causes COVID-19). You are likely contagious to others even if you are not experiencing symptoms.
IgM(+) and IgG(+)
There is a high probability that you have been infected with SARS-CoV-2 (the virus that causes COVID-19) and are in the late stages of a COVID-19 infection. You are still likely contagious to others even if you are not experiencing symptoms.
IgM(-) and IgG(+)
There is a high probability that you have been infected with SARS-CoV-2 (the virus that causes COVID-19) but have since recovered. You most likely have obtained some level of immunity. This does not exclude the possibility that you are still contagious. or that you could later be re-infected.
Disclaimer: This is not a medical diagnosis. Results from antibody testing should not be used as the sole basis to diagnose or exclude COVID-19 infection or to inform infection status. Negative results do not rule out a COVID-19 infection, particularly in those who have been in contact with the virus. Follow-up testing with a molecular diagnostic should be considered to rule out infection in these individuals. Positive results may be due to past or present infection with different coronavirus strains.